ONCOTIDE PHARMACEUTICALS, INC.

Company Information

Company Name
ONCOTIDE PHARMACEUTICALS, INC.
Address
BOX 110606, 79 TW ALEXANDER DR, BLDG 4401
RESEARCH TRIANGLE PARK, NC, 27709-0606
Phone
n/a
URL
n/a
DUNS
967354064
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
STTR Phase I
$600,000.00
2
Chart code to be here

Award List

  1. Novel SET Antagonists for the Treatment of Chronic Myelogenous Leukemia

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): Chronic Myelogenous Leukemia (CML) affects nearly 14,000 patients worldwide and is a disorder of the pluripotent hematopoietic stem cells with two distinct phases ...

    STTR Phase I 2012 Department of Health and Human Services
  2. Targeting c-Myc and Akt with PP2A reactivation therapy for the treatment of breas

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): Each year in the United States over 270,000 women will be diagnosed with breast cancer and over 40,000 will die from the disease. While multiple forms of breast ca ...

    STTR Phase I 2013 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government